Article Text

Download PDFPDF

P26. Cancer associated fibroblasts contribute to the immune suppression of breast cancer by augmentation of the inflammatory products
  1. L Langroudi1,
  2. ZM Hasan1,
  3. M Soleimani2 and
  4. SMM Hashemi3
  1. Aff1 grid.412266.50000000117813962ImmunologyTarbiat Modares University Tehran Iran
  2. Aff2 grid.412266.50000000117813962HaematologyTarbiat Modares University Tehran Iran
  3. Aff3 Stem Cell Technology CenterStem Cell Biology Tehran Iran

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Meeting abstracts


The supporting stroma of breast cancer is believed to support the growth and metastasis of cancer cells and are responsible for suppressing anti-cancer immune responses. In this regard we attempted to isolate and characterise the cancer associated fibroblasts (CAFs) of murine model of spontaneously developed breast cancer.


CAFs were isolated by explants culture of tumour tissue. The Fibroblast activated protein-alpha( FAP-α)-positive fibroblasts were co-cultured with splenocytes where the splenocyte proliferation and production of inflammatory and regulatory cytokines were assessed by ELISA. Also the inflammatory enzymes iNOS and the production of matrix metaloproteinases 2 and 9 by these cells were evaluated using Real-Time PCR.


Findings indicated enhanced in vitro immune suppression in co-cultures of CAF and splenocyte. Additionally, increased regulatory cytokine and inflammatory mediators was observed.


The secretory profile of these cells, as the supporting matrix, is a massive physical and immune barrier to anti-cancer immune therapy. Therefore it is proposed for enhancing the effect of therapy must take into acount the contribution of cancer associated fibroblasts on the chronic inflammatory microenvironment of breast cancer.